Pronucleotein Biotechnologies Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Pronucleotein Biotechnologies General Information

Description

Developer of deoxyribonucleic acid aptamer sequences and conjugates. The company's diagnostic platform for development and commercialization of a new food safety testing system can be used at any point in the global food supply chain, and provide results onsite within 30 minutes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • 4100 North West Loop 410
  • Suite 230
  • San Antonio, TX 78229
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pronucleotein Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pronucleotein Biotechnologies‘s full profile, request access.

Request a free trial

Pronucleotein Biotechnologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pronucleotein Biotechnologies‘s full profile, request access.

Request a free trial

Pronucleotein Biotechnologies FAQs

  • When was Pronucleotein Biotechnologies founded?

    Pronucleotein Biotechnologies was founded in 2005.

  • Who is the founder of Pronucleotein Biotechnologies?

    Lynda de la Vina is the founder of Pronucleotein Biotechnologies.

  • Where is Pronucleotein Biotechnologies headquartered?

    Pronucleotein Biotechnologies is headquartered in San Antonio, TX.

  • What industry is Pronucleotein Biotechnologies in?

    Pronucleotein Biotechnologies’s primary industry is Other Healthcare Services.

  • Is Pronucleotein Biotechnologies a private or public company?

    Pronucleotein Biotechnologies is a Private company.

  • What is Pronucleotein Biotechnologies’s current revenue?

    The current revenue for Pronucleotein Biotechnologies is 000000.

  • Who are Pronucleotein Biotechnologies’s investors?

    Texas Emerging Technology Fund has invested in Pronucleotein Biotechnologies.

  • When was Pronucleotein Biotechnologies acquired?

    Pronucleotein Biotechnologies was acquired on 14-Aug-2017.

  • Who acquired Pronucleotein Biotechnologies?

    Pronucleotein Biotechnologies was acquired by Seek Labs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »